Bikman says the added glucagon receptor push raises energy use and liver fat burning, and points to 24.2% weight loss on 12 mg in phase 2.
Recap by typeshit. Post by Benjamin Bikman on X.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
9:08
Archibald takes on a common question about low retatrutide doses and the drug's glucagon action. His view, not settled science, and retatrutide is still unapproved.
A report says an Eli Lilly drug helped protect muscle mass when combined with Novo's Wegovy, addressing a common worry about lean mass loss.
He says close to 40% of weight lost in the trial's body-scan group was lean mass, and argues muscle loss isn't the drug's fault.
The Sugarfit co-founder and the doctor argue that managing weight on GLP-1 medications takes more than the drug by itself.
She walks through the phase 3 data, including knee osteoarthritis results, and explains why she calls online reta vials a gamble.
Loading…